SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Press Releases
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
June 2, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
May 30, 2025
 · 
13 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
May 28, 2025
 · 
14 min read
Press Releases
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
May 5, 2025
 · 
20 min read
Press Releases
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
April 30, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
April 8, 2025
 · 
14 min read
Press Releases
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
April 7, 2025
 · 
14 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
March 10, 2025
 · 
15 min read
Press Releases
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
 · 
21 min read
Press Releases
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 27, 2025
 · 
14 min read
Press Releases
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
February 26, 2025
 · 
1 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 18, 2025
 · 
14 min read
Press Releases
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
February 12, 2025
 · 
6 min read
Press Releases
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
January 14, 2025
 · 
16 min read
Press Releases
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
 · 
1 min read
Press Releases
TG Therapeutics to Participate in the Evercore HealthCONx Conference
December 2, 2024
 · 
1 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS